These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18488222)

  • 1. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.
    Preise D; Oren R; Glinert I; Kalchenko V; Jung S; Scherz A; Salomon Y
    Cancer Immunol Immunother; 2009 Jan; 58(1):71-84. PubMed ID: 18488222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).
    Preise D; Scherz A; Salomon Y
    Photochem Photobiol Sci; 2011 May; 10(5):681-8. PubMed ID: 21258718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors.
    O'Shaughnessy MJ; Murray KS; La Rosa SP; Budhu S; Merghoub T; Somma A; Monette S; Kim K; Corradi RB; Scherz A; Coleman JA
    Clin Cancer Res; 2018 Feb; 24(3):592-599. PubMed ID: 28954788
    [No Abstract]   [Full Text] [Related]  

  • 4. WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice.
    Neuschmelting V; Kim K; Malekzadeh-Najafabadi J; Jebiwott S; Prakash J; Scherz A; Coleman JA; Kircher MF; Ntziachristos V
    Theranostics; 2018; 8(3):723-734. PubMed ID: 29344301
    [No Abstract]   [Full Text] [Related]  

  • 5. Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate.
    Fleshker S; Preise D; Kalchenko V; Scherz A; Salomon Y
    Photochem Photobiol; 2008; 84(5):1231-7. PubMed ID: 18399928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model.
    Mazor O; Brandis A; Plaks V; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A
    Photochem Photobiol; 2005; 81(2):342-51. PubMed ID: 15623318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.
    Kim K; Watson PA; Lebdai S; Jebiwott S; Somma AJ; La Rosa S; Mehta D; Murray KS; Lilja H; Ulmert D; Monette S; Scherz A; Coleman JA
    Clin Cancer Res; 2018 May; 24(10):2408-2416. PubMed ID: 29463549
    [No Abstract]   [Full Text] [Related]  

  • 8. Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad.
    Madar-Balakirski N; Tempel-Brami C; Kalchenko V; Brenner O; Varon D; Scherz A; Salomon Y
    PLoS One; 2010 Apr; 5(4):e10282. PubMed ID: 20421983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins.
    Brandis A; Mazor O; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A
    Photochem Photobiol; 2005; 81(4):983-93. PubMed ID: 15839743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.
    Alvim RG; Georgala P; Nogueira L; Somma AJ; Nagar K; Thomas J; Alvim L; Riegel A; Hughes C; Chen J; Reis AB; Lebdai S; Scherz A; Zanganeh S; Gardner R; Kim K; Coleman JA
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34205347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy.
    Kimm SY; Tarin TV; Monette S; Srimathveeravalli G; Gerber D; Durack JC; Solomon SB; Scardino PT; Scherz A; Coleman J
    Radiology; 2016 Oct; 281(1):109-18. PubMed ID: 26986047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.
    Yeung HY; Lo PC; Ng DK; Fong WP
    Cell Mol Immunol; 2017 Feb; 14(2):223-234. PubMed ID: 26388236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
    Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.
    Kim K; Zhang H; La Rosa S; Jebiwott S; Desai P; Kimm S; Scherz A; O'Donoghue JA; Weber WA; Coleman JA
    Clin Cancer Res; 2017 Jul; 23(13):3343-3351. PubMed ID: 28108545
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor Effects of DC Vaccine With ALA-PDT-Induced Immunogenic Apoptotic Cells for Skin Squamous Cell Carcinoma in Mice.
    Zhang H; Wang P; Wang X; Shi L; Fan Z; Zhang G; Yang D; Bahavar CF; Zhou F; Chen WR; Wang X
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818785275. PubMed ID: 30025490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response.
    Hamblin MR; Abrahamse H
    Anticancer Agents Med Chem; 2021; 21(2):123-136. PubMed ID: 32188394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.
    Lamberti MJ; Mentucci FM; Roselli E; Araya P; Rivarola VA; Rumie Vittar NB; Maccioni M
    Front Immunol; 2019; 10():2614. PubMed ID: 31781113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
    Mroz P; Szokalska A; Wu MX; Hamblin MR
    PLoS One; 2010 Dec; 5(12):e15194. PubMed ID: 21179470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
    Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
    Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.